Greenwich lifesciences inc

WebSep 6, 2024 · Greenwich LifeSciences, Inc. is a one-man, one-asset shop. The asset, GP2, has produced excellent breast cancer data. Greenwich LifeSciences' CEO, Snehal Patel, runs this company almost all by ... WebMar 13, 2024 · 12.48. USD. -1.34%. 04/10. HC Wainwright Cuts Greenwich LifeSciences' Price Target to $38 From $78, Keeps Buy Rating. MT. 03/31. GREENWICH LIFESCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)

Insider Buying: The Greenwich LifeSciences, Inc. (NASDAQ:GLSI) …

WebApr 10, 2024 · Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients. WebGreenwich LifeSciences Inc. GLSI (U.S.: Nasdaq) Overview Profile Financials Income Statement Balance Sheet Cash Flow Research & Ratings Historical Prices Options … shard of crystallized mists essence farm https://jamconsultpro.com

Greenwich LifeSciences: Persevering CEO And …

WebApr 10, 2024 · 31/03 Greenwich LifeSciences, Inc. annonce ses résultats pour l'exercice clos le 31 décembre ... WebApr 13, 2024 · Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Rating) VP Jaye Thompson purchased 1,000 shares of the firm’s stock in a transaction dated Tuesday, … WebSnehal S. Patel Chief Executive Officer. Over 30 years of experience in executive management, corporate development, operations, and investment banking in the … pooleside pies raleigh nc

Greenwich LifeSciences - Crunchbase Company Profile

Category:Corporate Governance Greenwich LifeSciences, Inc. (GLSI) GP2

Tags:Greenwich lifesciences inc

Greenwich lifesciences inc

Greenwich LifeSciences Announces Update of GP2 Phase III …

WebMar 3, 2024 · Investor & Public Relations Contact for Greenwich LifeSciences Dave Gentry RedChip Companies Inc. Office: 1-800-RED CHIP (733 2447) Cell: (407) 491-4498 Email: [email protected] Release Summary WebGreenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. …

Greenwich lifesciences inc

Did you know?

WebApr 10, 2024 · A rating of 81 puts Greenwich Lifesciences Inc ( GLSI) near the top of the Healthcare sector according to InvestorsObserver . Greenwich Lifesciences Inc's score … WebFind real-time GLSI - Greenwich Lifesciences Inc stock quotes, company profile, news and forecasts from CNN Business.

WebApr 14, 2024 · Whilst it may not be a huge deal, we thought it was good to see that the Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO, CFO & Director, Snehal Patel, …

WebApr 14, 2024 · Greenwich LifeSciences, Inc. has a 1-year low of $6.82 and a 1-year high of $21.50. The stock has a market cap of $153.81 million, a PE ratio of -21.00 and a beta of … WebApr 6, 2024 · Greenwich Lifesciences Inc ( GLSI) is around the top of the Biotechnology industry according to InvestorsObserver. GLSI received an overall rating of 62, which means that it scores higher than 62 percent of all stocks.

WebSep 29, 2024 · STAFFORD, Texas-- ( BUSINESS WIRE )--Greenwich LifeSciences, Inc. (the “Company”), a clinical-stage biopharmaceutical company focused on the …

WebDec 1, 2024 · STAFFORD, Texas, December 01, 2024 -- ( BUSINESS WIRE )--Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of... shard offer codeWebApr 14, 2024 · On Friday, March 10th, Snehal Patel bought 1,000 shares of Greenwich LifeSciences stock. The stock was bought at an average cost of $12.12 per share, with a total value of $12,120.00. shard of evil liodenWebApr 14, 2024 · Greenwich LifeSciences, Inc. has a 12-month low of $6.82 and a 12-month high of $21.50. The firm’s 50-day moving average price is $14.92 and its two-hundred … pooles moving and storageWebJan 5, 2024 · Greenwich LifeSciences, Inc. 13.21 +0.20 +1.58%: TRENDING. 1. Battery maker Northvolt in talks for over $5 billion in financing -FT. 2. Aging Shadow Fleet Carrying Russian Oil Poses Disaster Risk. 3. shard offer 2 for 1WebApr 14, 2024 · Greenwich LifeSciences, Inc. has a 1-year low of $6.82 and a 1-year high of $21.50. The stock has a market cap of $153.81 million, a PE ratio of -21.00 and a beta of 0.93. pooles moving taylors scWebApr 14, 2024 · Greenwich LifeSciences has a 52-week low of $6.82 and a 52-week high of $21.50. The stock’s fifty day simple moving average is $14.92 and its 200-day simple moving average is $13.48. The... shard of domination traderWebApr 11, 2024 · NASDAQ:GLSI opened at $12.65 on Monday. Greenwich LifeSciences has a 52 week low of $6.82 and a 52 week high of $21.50. The stock’s fifty day moving average is $15.24 and its two-hundred day ... shard of crystallized blood of jormag